
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DIMETANE-DX | A.H. Robins Company | N-019279 DISCN | 1984-08-24 | 1 products, RLD |
Brand Name | Status | Last Update |
|---|---|---|
| altipres-b | C200263 | 2024-12-26 |
| atuss da | OTC monograph final | 2021-11-02 |
| balahist | OTC monograph final | 2013-11-11 |
| basic care childrens cold and cough | C200263 | 2024-11-17 |
| bio dtuss | C200263 | 2024-12-20 |
| bio t pres-b | OTC monograph final | 2012-12-18 |
| brom tapp | OTC monograph final | 2018-04-30 |
| brom tapp dm | OTC monograph final | 2018-04-30 |
| bromfed | ANDA | 2015-09-01 |
| bromfed dm | ANDA | 2021-01-11 |
Code | Description |
|---|---|
| J0945 | Injection, brompheniramine maleate, per 10 mg |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | — | 1 | 6 | 1 | — | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inflammation | D007249 | MP_0001845 | — | — | — | 3 | — | — | 3 |
| Rhinitis | D012220 | EFO_0008521 | J31 | — | — | 3 | — | — | 3 |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | — | — | 1 | — | — | 1 |
| Cough | D003371 | — | R05 | — | — | 1 | — | — | 1 |
| Common cold | D003139 | EFO_0007214 | J00 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chronic pain | D059350 | — | — | — | 1 | — | — | — | 1 |
| Substance withdrawal syndrome | D013375 | EFO_0005800 | — | 1 | 1 | — | — | — | 1 |
| Neonatal abstinence syndrome | D009357 | EFO_0005799 | P96.1 | 1 | 1 | — | — | — | 1 |
| Head and neck neoplasms | D006258 | — | — | — | 1 | — | — | — | 1 |
| Mouth neoplasms | D009062 | EFO_0003868 | C06.9 | — | 1 | — | — | — | 1 |
| Pharyngeal neoplasms | D010610 | — | C14.0 | — | 1 | — | — | — | 1 |
| Laryngeal neoplasms | D007822 | EFO_0003817 | C32 | — | 1 | — | — | — | 1 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 1 | 1 |
| Drug common name | Brompheniramine |
| INN | brompheniramine |
| Description | Brompheniramine is pheniramine in which the hydrogen at position 4 of the phenyl substituent is substituted by bromine. A histamine H1 receptor antagonist, brompheniramine is used (commonly as its maleate salt) for the symptomatic relief of allergic conditions, including rhinitis and conjunctivitis. It has a role as a H1-receptor antagonist and an anti-allergic agent. It is a member of pyridines and an organobromine compound. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CN(C)CCC(c1ccc(Br)cc1)c1ccccn1 |
| PDB | — |
| CAS-ID | 86-22-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL811 |
| ChEBI ID | 3183 |
| PubChem CID | 6834 |
| DrugBank | DB00835 |
| UNII ID | H57G17P2FN (ChemIDplus, GSRS) |



















































